| Literature DB >> 31623693 |
Eric Matsiko1,2, Paul J M Hulshof1, Laura van der Velde1, Marlou-Floor Kenkhuis1, Lisine Tuyisenge3, Alida Melse-Boonstra1.
Abstract
Saliva and urine are the two main body fluids sampled when breast milk intake is measured with the 2H oxide dose-to-mother technique. However, these two body fluids may generate different estimates of breast milk intake due to differences in isotope enrichment. Therefore, we aimed to assess how the estimated amount of breast milk intake differs when based on saliva and urine samples and to explore whether the total energy expenditure of the mothers is related to breast milk output. We used a convenience sample of thirteen pairs of mothers and babies aged 2-4 months, who were exclusively breastfed and apparently healthy. To assess breast milk intake, we administered doubly labelled water to the mothers and collected saliva samples from them, while simultaneously collecting both saliva and urine from their babies over a 14-d period. Isotope ratio MS was used to analyse the samples for 2H and 18O enrichments. Mean breast milk intake based on saliva samples was significantly higher than that based on urine samples (854·5 v. 812·8 g/d, P = 0·029). This can be attributed to slightly higher isotope enrichments in saliva and to a poorer model fit for urine samples as indicated by a higher square root of the mean square error (14·6 v. 10·4 mg/kg, P = 0·001). Maternal energy expenditure was not correlated with breast milk output. Our study suggests that saliva sampling generates slightly higher estimates of breast milk intake and is more precise as compared with urine and that maternal energy expenditure does not influence breast milk output.Entities:
Keywords: 2H oxide dose-to-mother technique; Breast milk intake; Doubly labelled water; Maternal energy expenditure; Saliva samples: Urine samples
Year: 2019 PMID: 31623693 PMCID: PMC7015877 DOI: 10.1017/S0007114519002642
Source DB: PubMed Journal: Br J Nutr ISSN: 0007-1145 Impact factor: 3.718
Fig. 1.Study flow diagram: summary of the main steps of the study.
Characteristics of the study participants
(Mean values and standard deviations; numbers of participants)
| Dutch | Rwandan | All | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Characteristics | Mean |
| Mean |
| Mean |
| |||
| Number of mother–child pairs | 5 | 8 | 13 | ||||||
| Child | |||||||||
| Sex ratio (male:female) | 1:4 | 5:3 | 6:7 | ||||||
| Age (months) | 3·4 | 1·0 | 3·7 | 0·6 | 3·6 | 0·7 | |||
| Weight at day 0 (kg) | 6·0 | 0·5 | 6·8 | 1·7 | 6·5 | 1·4 | |||
| Weight at day 14 (kg) | 6·4 | 0·7 | 6·6 | 0·9 | 6·8 | 1·3 | |||
| Weight gain (g/d) | 20·8 | 17·3 | 19·6 | 18·5 | 20·2 | 17 | |||
| Length (cm) | 61·7 | 1·7 | 60·5 | 2·5 | 61·0 | 2·3 | |||
| BMI-for-age | 0·14 | 1·3 | 0·99 | 1·8 | 0·66 | 1·6 | |||
| Body water (kg) | 3·7 | 0·2 | 3·9 | 0·6 | 3·9 | 0·5 | |||
| Fat-free mass (kg) | 4·7 | 0·3 | 5·0 | 0·7 | 4·9 | 0·6 | |||
| Fat mass (kg) | 1·6 | 0·3 | 1·5 | 0·4 | 1·6 | 0·3 | |||
| Fat mass (%) | 25·7 | 2·3 | 23·7 | 5·1 | 24·5 | 5·1 | |||
| Mother | |||||||||
| Age (years) | 30·8 | 0·8 | 30·5 | 6·1 | 30·6 | 4·6 | |||
| Body weight at day 0 (kg) | 63·8 | 13·2 | 60·2 | 5·3 | 61·5 | 8·8 | |||
| Height (cm) | 165·3 | 3·3 | 160·9 | 7·2 | 162·6 | 2·2 | |||
| BMI (kg/m2) | 23·1 | 4·7 | 23·4 | 2·6 | 23·2 | 3·4 | |||
| Total body water (kg) | 30·2 | 2·4 | 30·0 | 2·7 | 30·0 | 2·5 | |||
| Fat-free mass (kg) | 41·0 | 3·4 | 41·0 | 3·7 | 40·9 | 3·4 | |||
| Fat mass (kg) | 22·5 | 13 | 19·3 | 3·6 | 20·5 | 8·1 | |||
| Fat mass (%) | 33·2 | 10·6 | 31·9 | 4·4 | 32·4 | 7 | |||
Kinetic parameters for analysis of doubly labelled water
|
| Abundance at 14 d | Isotope elimination rate: kO/kD | ||||
|---|---|---|---|---|---|---|
| Participant | 2H | 18O | Dilution space: 2H/18O | 2H | 18O | |
| D1 | 0·998 | 0·998 | 1·037 | 56·9 | 29·9 | 1·2 |
| D2 | 0·999 | 0·999 | 1·012 | 81·6 | 21·8 | 1·3 |
| D3 | 0·999 | 0·999 | 1·005 | 71·5 | 22·8 | 1·2 |
| D4 | 0·994 | 0·997 | 0·997 | 69·3 | 22·8 | 1·2 |
| D5 | 0·999 | 0·999 | 1·006 | 70·5 | 22·6 | 1·2 |
| RW1 | 0·999 | 0·999 | 1·046 | 41·5 | 16·8 | 1·3 |
| RW2 | 0·998 | 0·999 | 1·069 | 51·8 | 23·6 | 1·3 |
| RW3 | 0·999 | 0·999 | 1·047 | 48·3 | 22·6 | 1·3 |
| RW4 | 0·999 | 0·999 | 1·061 | 48·5 | 25·3 | 1·2 |
| RW5 | 0·999 | 0·998 | 1·030 | 60·6 | 26·7 | 1·3 |
| RW6 | 0·999 | 0·999 | 1·014 | 47·5 | 22·7 | 1·2 |
| RW7 | 0·999 | 0·994 | 1·018 | 42·3 | 17·0 | 1·3 |
| RW8 | 0·998 | 0·999 | 1·043 | 48·9 | 23·0 | 1·3 |
| Range | 0·994–0·999 | 0·997–1·069 | 41·5–81·6 | 16·8–29·9 | 1·2–1·3 | |
R 2, coefficient of the determination regression line; 18O, oxygen-18; kO, oxygen-18 elimination rate; kD, 2H elimination rate; D, Dutch; RW, Rwandan.
Kinetic results based on saliva and urine body fluids
(Mean values and standard deviations)
| Outcome | Saliva | Urine | Saliva | Urine | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dutch | Rwandan | Dutch | Rwandan | All | All | ||||||||
| Mean |
| Mean |
| Mean |
| Mean |
| Mean |
| Mean |
|
| |
|
2H enrichment (ppm) | 53·2 | 11·0 | 43·6 | 11·50 | 50·0 | 9·9 | 39·7 | 10·6 | 47·4 | 11·7 | 43·8 | 11·1 | 0·049 |
|
2H enrichment (ppm) | 102·3 | 10·6 | 78·0 | 19·24 | 98·3 | 17·3 | 75·9 | 21·4 | 86·8 | 21·1 | 84·0 | 22·2 | 0·090 |
|
2H enrichment (ppm) | 131·8 | 16·6 | 95·3 | 24·9 | 130·1 | 17·9 | 88·8 | 22·3 | 109·9 | 28·1 | 105·3 | 28·9 | 0·031 |
|
2H enrichment (ppm) | 151·0 | 14·8 | 113·9 | 19·4 | 154·2 | 15·8 | 108·4 | 17·3 | 127·4 | 25·3 | 125·1 | 28·0 | 0·371 |
|
2H enrichment (ppm) | 115·1 | 7·5 | 74·5 | 10·2 | 113·0 | 11·0 | 71·9 | 11·8 | 88·1 | 21·2 | 85·6 | 23·0 | 0·054 |
|
2H enrichment (ppm) | 106·8 | 8·3 | 67·0 | 9·0 | 106·4 | 8·2 | 66·1 | 9·6 | 80·3 | 20·5 | 79·5 | 21·6 | 0·313 |
| Mean 2H enrichment (ppm) | 110·0 | 10·5 | 78·6 | 14·7 | 108·6 | 11·6 | 76·8 | 14·8 | 89·3 | 20·0 | 87·4 | 20·5 | 0·106 |
| AUC (ppm) | 1994 | 226·2 | 1283·8 | 202·4 | 1924·4 | 253·3 | 1230·0 | 202·1 | 1504·1 | 382·0 | 1461·5 | 400·4 | 0·009 |
| Square root MSE (mg/kg) | 12·8 | 11·0 | 9·1 | 2·9 | 17·2 | 8·1 | 13·3 | 5·0 | 10·4 | 6·4 | 14·6 | 6·1 | 0·001 |
| Breast milk output (g/d) | 760·2 | 65·6 | 901·6 | 261·2 | 748·7 | 77·1 | 844·8 | 221·2 | 854·5 | 222·3 | 812·8 | 187·1 | 0·029 |
| Non-milk oral water intake (g/d) | −11·7 | 16·2 | 34·2 | 115·8 | −7·5 | 20·5 | 70·5 | 129·7 | 18·9 | 95·5 | 44·5 | 110·9 | 0·022 |
| Daily energy intake (kJ/d) | 2502·0 | 652·7 | 2380·7 | 548·1 | 0·029 | ||||||||
T, time (h) of sample collection after dosing; S, saliva; U, urine; ppm, parts per million; MSE, mean squared error, which is the differences between the measured and model-predicted 2H enrichment in the mother and child.
P value between saliva and urine estimates of each outcome for all participants.
Energy intake is estimated based energy density of 2·93 kJ/g according to Dewey et al.(.
Fig. 2.Bland and Altman plot of the differences of breast milk intakes (saliva – urine) plotted against mean intakes ((saliva + urine)/2). The central plain line is the mean difference in breast milk intakes from saliva and urine (41·6 g/d). The lower and upper thick dashed lines indicate the mean difference plus two standard deviations (mean, 2sd = −72·76, 157·08). The thin dotted lines indicate the CI for the mean (4·9, 78·3), lower limit (−93·6, −52) and the CI for the upper limit (136·2, 178·0). The numbers in the figure represent the participants per country (2–5 for Dutch and 6–12 for Rwandans).
Fig. 3.Correlation between maternal energy expenditure and breast milk intake (r 0·33; P = 0·284).